Alexandra Pasi has been in the data and AI/ML space for over a decade. Since earning her PhD in Mathematics from Baylor University, she's worked with companies at different stages, from startup to enterprise to help them develop and execute strategies to deliver value through their data and technology. She has built and led high-performing teams from the ground-up, and successfully brought cutting edge R&D technology to market. Her industry and research experience includes diverse fields such as finance, genomics, marketing, and machine learning. As the CEO and Co-Founder of Lucidity Sciences, she leads the team bringing Aleph One, a breakthrough new ML technology, to the frontlines of industry and scientific applications.
Dr. Richard Wellman brings decades of experience in Machine Learning and the development of novel technologies to Lucidity Sciences. He was instrumental in the development of early commercial machine learning technology, having developed patented technologies for automating predictive analytics and ensemble learning. He has served as faculty and a visiting professor in the Mathematics and Computer Science departments of multiple universities, including Baylor University, Westminster University, and Colorado College, and has published several papers in functional analysis and theoretical computer science.
With a background in optimization and the inner workings of complex systems, Alan provides a keen eye in finding what makes a process tick, and how to make it tick better. Alan's PhD focus centered around highly nonlinear PDE in the context of high population competitive dynamics. With a desire to optimize something more tangible, Alan turned to technology, successfully delivering cost cutting petabyte scale pipeline architectures and has developed patent-pending technology for data analytics. Alan uses his experience from years of teaching to communicate intricate concepts across audiences, allowing him to effectively champion innovation across technology and business teams.
Brian brings nearly three decades of clinical laboratory science and leadership experience to Lucidity Sciences. As the leader of a cellular immunology lab positioned at the interface of R&D and clinical laboratory science, he has extensive experience with the implementation and commercialization of cutting-edge new technologies in healthcare settings. He has planned and overseen the development of emerging medical device technologies. He is published in the fields of Clinical Chemistry, Immunology, and Clinical Pathology. He is also an avid outdoorsman and mountaineer.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.